Be Alert for Axillary Adenopathy After COVID-19 Vaccination

Chelsea Backler MSN, APRN, AGCNS-BC, AOCNS®
Voice

Description

Nearly 60 million people in the United States and almost 200 million around the world have received the COVID-19 coronavirus vaccine as of mid-February 2021, and the numbers will continue to grow as more doses come to market and other manufacturers’ versions receive emergency use authorizations. As more people get vaccinated, some of the expected side effects are being observed in clinical practice and have implications for cancer care. 

View Article @ voice.ons.org

ONS Voice Articles

ONS's member magazine articles.

View All Voice Articles

Related Topics